Orchestra BioMed Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q3 2024.
  • Orchestra BioMed Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$15.4M, a 15.8% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$57.7M, a 25.3% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$49.1M, a 46.2% decline from 2022.
  • Orchestra BioMed Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.6M, a 8773% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$15.4M -$2.11M -15.8% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$16M -$3.93M -32.7% Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$13.5M -$2.52M -23.1% Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$12.8M -$3.07M -31.5% Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$13.3M -$3.03M -29.5% Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$12M -$4.2M -53.5% Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$10.9M -$5.21M -91% Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$9.75M -$9.66M -10978% Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$10.3M -$10.2M -11273% Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$7.85M -$7.75M -8399% Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$5.73M -$5.62M -5205% Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$88K Dec 31, 2021 10-K 2023-01-25
Q3 2021 -$90.4K -$24.2K -36.5% Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$92.3K -$77.1K Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$108K Mar 31, 2021 10-Q 2022-11-14
Q3 2020 -$66.2K Sep 30, 2020 10-Q/A 2022-03-31
Q2 2020 -$15.2K* Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.